0001140361-18-018960.txt : 20180418 0001140361-18-018960.hdr.sgml : 20180418 20180418174631 ACCESSION NUMBER: 0001140361-18-018960 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180417 FILED AS OF DATE: 20180418 DATE AS OF CHANGE: 20180418 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jackson Steven D. CENTRAL INDEX KEY: 0001654405 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35929 FILM NUMBER: 18762044 MAIL ADDRESS: STREET 1: C/O NATIONAL RESEARCH CORPORATION STREET 2: 1245 Q STREET CITY: LINCOLN STATE: NE ZIP: 68508 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NATIONAL RESEARCH CORP CENTRAL INDEX KEY: 0000070487 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 470634000 STATE OF INCORPORATION: WI FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1245 Q STREET CITY: LINCOLN STATE: NE ZIP: 68508 BUSINESS PHONE: 4024752525 MAIL ADDRESS: STREET 1: 1245 Q STREET CITY: LINCOLN STATE: NE ZIP: 68508 4 1 doc1.xml FORM 4 X0306 4 2018-04-17 0 0000070487 NATIONAL RESEARCH CORP NRCIA/B 0001654405 Jackson Steven D. C/O NATIONAL RESEARCH CORPORATION 1245 Q STREET LINCOLN NE 68508 0 1 0 0 President Class B Common Stock 2018-04-17 4 D 0 15245 D 0 D Common Stock 2018-04-17 4 A 0 15245 A 108478 D Common Stock 2018-04-17 4 A 0 1989 A 110467 D Common Stock 2018-04-17 4 F 0 4991 33.55 D 105476 D Employee Stock Option (Right to Buy) 34 2018-04-17 4 D 0 3589 D 2026-01-05 Class B Common Stock 3589 0 D Employee Stock Option (Right to Buy) 40.54 2018-04-17 4 D 0 2935 D 2027-01-04 Class B Common Stock 2935 0 D Employee Stock Option (Right to Buy) 15.23 2026-01-05 Common Stock 21535 21535 D Employee Stock Option (Right to Buy) 18.80 2027-01-04 Common Stock 17608 17608 D Employee Stock Option (Right to Buy) 36.80 2028-01-03 Common Stock 12228 12228 D On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization"). Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option and any applicable tax withholding. This option becomes fully exercisable on January 5, 2021. This option becomes fully exercisable on January 4, 2022. This option becomes fully exercisable on January 3, 2023. /s/ Russell E. Ryba, Attorney-in-Fact for Steven D. Jackson 2018-04-18